Insider Transactions in Q3 2022 at Cidara Therapeutics, Inc. (CDTX)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 19
2022
|
Preetam Shah Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,642
-9.4%
|
$0
$0.77 P/Share
|
Sep 15
2022
|
Preetam Shah Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+23.1%
|
-
|
Sep 12
2022
|
Taylor Sandison Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,478
-5.96%
|
$0
$0.68 P/Share
|
Sep 12
2022
|
Leslie Tari CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
18,159
-8.57%
|
$0
$0.68 P/Share
|
Sep 12
2022
|
Paul Daruwala Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
16,199
-6.83%
|
$0
$0.68 P/Share
|